Kanchanok Kodchakorn

Dr. Kanchanok Kodchakorn

Thailand Excellence Center for Tissue Engineering and Stem Cells
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Journal of Molecular Graphics and Modelling
Verified
Journal Article
Closed access
Kanchanok KodchakornKanchanok Kodchakorn
Kanchanok Kodchakorn
YPYong Poovorawan
Yong Poovorawan
KSKamol Suwannakarn
Kamol Suwannakarn
PKPrachya Kongtawelert
Prachya Kongtawelert

30 September 2015 in In Vitro Cellular & Developmental Biology - Animal
Verified
Journal Article
Closed access
PDF file
KFKanda Fanhchaksai
Kanda Fanhchaksai
Kanchanok KodchakornKanchanok Kodchakorn
Kanchanok Kodchakorn
PPPeraphan Pothacharoen
Peraphan Pothacharoen
PKPrachya Kongtawelert
Prachya Kongtawelert

30 May 2012 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
APAdchara Prommaban
Adchara Prommaban
Kanchanok KodchakornKanchanok Kodchakorn
Kanchanok Kodchakorn
PKPrachya Kongtawelert
Prachya Kongtawelert
RBRatana Banjerdpongchai
Ratana Banjerdpongchai
Houttuynia cordata Thunb Fraction Induces Human Leukemic Molt-4 Cell Apoptosis through the Endoplasmic Reticulum Stress Pathway Houttuynia cordata Thunb;apoptosis;human leukemic Molt-4 cells;endoplasmic reticulum stress; Houttuynia cordata Thunb (HCT) is a native herb found in Southeast Asia which features various pharmacological activities against allergy, inflammation, viral and bacterial infection, and cancer. The aims of this study were to determine the cytotoxic effect of 6 fractions obtained from silica gel column chromatography of alcoholic HCT extract on human leukemic Molt-4 cells and demonstrate mechanisms of cell death. Six HCT fractions were cytotoxic to human lymphoblastic leukemic Molt-4 cells in a dose-dependent manner by MTT assay, fraction 4 exerting the greatest effects. Treatment with $IC_{50}$ of HCT fraction 4 significantly induced Molt-4 apoptosis detected by annexinV-FITC/propidium iodide for externalization of phosphatidylserine to the outer layer of cell membrane. The mitochondrial transmembrane potential was reduced in HCT fraction 4-treated Molt-4 cells. Moreover, decreased expression of Bcl-xl and increased levels of Smac/Diablo, Bax and GRP78 proteins were noted on immunoblotting. In conclusion, HCT fraction 4 induces Molt-4 apoptosis cell through an endoplasmic reticulum stress pathway.

21 August 2009 in Protein Science
Verified
Journal Article
Open access
PDF file
SSSupachai Sakkhachornphop
Supachai Sakkhachornphop
SJSupat Jiranusornkul
Supat Jiranusornkul
Kanchanok KodchakornKanchanok Kodchakorn
Kanchanok Kodchakorn
SNSawitree Nangola
Sawitree Nangola
TSThira Sirisanthana
Thira Sirisanthana
CTChatchai Tayapiwatana
Chatchai Tayapiwatana
Integration of HIV‐1 cDNA into the host genome is a crucial step for viral propagation. Two nucleotides, cytosine and adenine (CA), conserved at the 3′ end of the viral cDNA genome, are cleaved by the viral integrase (IN) enzyme. As IN plays a crucial role in the early stages of the HIV‐1 life cycle, substrate blockage of IN is an attractive strategy for therapeutic interference. In this study, we used the 2‐LTR‐circle junctions of HIV‐1 DNA as a model to design zinc finger protein (ZFP) targeting at the end terminal portion of HIV‐1 LTR. A six‐contiguous ZFP, namely 2LTRZFP was designed using zinc finger tools. The designed motif was expressed and purified from E. coli to determine its binding properties. Surface plasmon resonance (SPR) was used to determine the binding affinity of 2LTRZFP to its target DNA. The level of dissociation constant (Kd) was 12.0 nM. The competitive SPR confirmed that 2LTRZFP specifically interacted with its target DNA. The qualitative binding activity was subsequently determined by EMSA and demonstrated the aforementioned correlation. In addition, molecular modeling and binding energy analyses were carried out to provide structural insight into the binding of 2LTRZFP to the specific and nonspecific DNA target. It is suggested that hydrogen‐bonding interactions play a key role in the DNA recognition mechanisms of the designed ZFP. Our study suggested an alternative HIV therapeutic strategy using ZFP interference of the HIV integration process.

16 March 2023 in International Immunopharmacology
Verified
Journal Article
Closed access
BWBenjawan Wudtiwai
Benjawan Wudtiwai
Kanchanok KodchakornKanchanok Kodchakorn
Kanchanok Kodchakorn
TSThuzar Hla Shwe
Thuzar Hla Shwe
PPPeraphan Pothacharoen
Peraphan Pothacharoen
TPThanyaluck Phitak
Thanyaluck Phitak
PKPrachya Kongtawelert
Prachya Kongtawelert

29 June 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PHPayuda Hansoongnern
Payuda Hansoongnern
PPPornpitra Pratedrat
Pornpitra Pratedrat
PNPornjarim Nilyanimit
Pornjarim Nilyanimit
RWRujipat Wasitthankasem
Rujipat Wasitthankasem
NPNawarat Posuwan
Nawarat Posuwan
YPYong Poovorawan
Yong Poovorawan
Hepatitis C virus (HCV) is a viral pathogen that causes chronic hepatitis, which can lead to cirrhosis and hepatocellular carcinoma. Detection of HCV RNA is the standard method used to diagnose the disease and monitor antiviral treatment. A quantification assay for the HCV core antigen (HCVcAg) has been proposed as a simplified alternative to the HCV RNA test for predicting active HCV infection, with the aim of achieving the global goal of eliminating hepatitis. The objective of this study was to determine the correlation between HCV RNA and HCVcAg, as well as the impact of amino acid sequence heterogeneity on HCVcAg quantification. Our findings demonstrated a strong positive correlation between HCV RNA and HCVcAg across all HCV genotypes (1a, 1b, 3a, and 6), with correlation coefficients ranging from 0.88 to 0.96 (p < 0.001). However, in some cases, samples with genotypes 3a and 6 exhibited lower HCVcAg levels than expected based on the corresponding HCV RNA values. Upon the core amino acid sequence alignment, it was observed that samples exhibiting low core antigen levels had an amino acid substitution at position 49, where threonine was replaced by either alanine or valine. Core mutation at this position may correlate with one of the epitope regions recognized by anti-HCV monoclonal antibodies. The present findings suggest that the utilization of HCVcAg as a standalone marker for HCV RNA might not provide adequate sensitivity for the detection of HCV infection, especially in cases where there are variations in the amino acid sequence of the core region and a low viral load of HCV RNA.